Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year.
Tianjin TEDA Biomedical Engineering Co's 10-Year ROIIC % for the quarter that ended in Dec. 2025 was 39.91%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Tianjin TEDA Biomedical Engineering Co (FRA:TJJ) 10-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Tianjin TEDA Biomedical Engineering Co 10-Year ROIIC % Related Terms
Tianjin TEDA Biomedical Engineering Co 10-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tianjin TEDA Biomedical Engineering Co 10-Year ROIIC % Chart
Tianjin TEDA Biomedical Engineering Co Annual Data
FRA:TJJ vs CTVA, CF, MOS: 10-Year ROIIC % Comparison
For the Agricultural Inputs subindustry, Tianjin TEDA Biomedical Engineering Co's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tianjin TEDA Biomedical Engineering Co 10-Year ROIIC % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Tianjin TEDA Biomedical Engineering Co's 10-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Tianjin TEDA Biomedical Engineering Co's 10-Year ROIIC % falls into.
10-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
10-Year Incremental Invested Capital**
=
( 0.765 (Dec. 2025) - 4.3942965 (Dec. 2015) )
/
( 32.335 (Dec. 2025) - 43.834 (Dec. 2015) )
=
-3.6292965
/
-11.499
=
31.56%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Tianjin TEDA Biomedical Engineering Co (FRA:TJJ) has a 10-Year ROIIC % of 39.91 as of Dec. 2025. 10-Year ROIIC % measures the change in earnings as a percentage of change in investment over 10-year. View historical data on Tianjin TEDA Biomedical Engineering Co and its competitors. According to the industry distribution chart, Tianjin TEDA Biomedical Engineering Co ranks #16 out of 225 companies in the Agriculture industry, placing it in the top 7.1%.
Is Tianjin TEDA Biomedical Engineering Co's 10-Year ROIIC % too high?
Tianjin TEDA Biomedical Engineering Co's current 10-Year ROIIC % is 39.91. The Agriculture industry median 10-Year ROIIC % is 4.33. Tianjin TEDA Biomedical Engineering Co's value of 39.91 is 821.7% above this industry median. Based on the distribution chart, Tianjin TEDA Biomedical Engineering Co ranks #16 out of 225 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, Tianjin TEDA Biomedical Engineering Co has a GF Score™ of 28/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tianjin TEDA Biomedical Engineering Co's 10-Year ROIIC % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Tianjin TEDA Biomedical Engineering Co ranks #16 out of 225 companies for 10-Year ROIIC %. This places Tianjin TEDA Biomedical Engineering Co in the top 7% of its industry — outperforming the majority of peers. The industry median 10-Year ROIIC % is 4.33. Tianjin TEDA Biomedical Engineering Co's value of 39.91 is 821.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year ROIIC % for an Agriculture company?
The median 10-Year ROIIC % among Agriculture companies is 4.33, based on 225 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tianjin TEDA Biomedical Engineering Co's current 10-Year ROIIC % of 39.91 is 821.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year ROIIC % mean?
A high 10-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 10-Year ROIIC % measures the change in earnings as a percentage of change in investment over 10-year. View historical data on Tianjin TEDA Biomedical Engineering Co and its competitors. For the Agriculture industry, the median 10-Year ROIIC % is 4.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tianjin TEDA Biomedical Engineering Co's current 10-Year ROIIC % is 39.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tianjin TEDA Biomedical Engineering Co stock overvalued right now?
Based on GuruFocus' analysis, Tianjin TEDA Biomedical Engineering Co (FRA:TJJ) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.01, compared to a current price of €0.02 — trading 115% above its estimated fair value. The current 10-Year ROIIC % is 39.91 and 821.7% above the Agriculture industry median of 4.33. Tianjin TEDA Biomedical Engineering Co's overall GF Score™ is 28/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year ROIIC % calculated?
10-Year ROIIC % is calculated from a company's financial statements. For Tianjin TEDA Biomedical Engineering Co (FRA:TJJ), the current 10-Year ROIIC % is 39.91 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tianjin TEDA Biomedical Engineering Co (FRA:TJJ) Overvalued in 2026?
Based on GuruFocus' analysis, Tianjin TEDA Biomedical Engineering Co stock appears to be overvalued.
The current stock price of €0.02 is trading 115% above its estimated GF Value™ of €0.01.
GuruFocus considers Tianjin TEDA Biomedical Engineering Co to be Significantly Overvalued.
Key valuation signals for FRA:TJJ:
10-Year ROIIC %: 39.91
GF Value™: €0.01 vs. price of €0.02 (115% above fair value)
Industry Position: 821.7% above the Agriculture median (#16 of 225)
No single metric tells the full story. See the FRA:TJJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tianjin TEDA Biomedical Engineering Co Ltd principally engages in manufacture and sale of biological compound fertiliser products and elderly care and health care services and related products. The group is principally engaged in manufacturing and selling biological compound fertilisers, AI health & elderly care products and services. It operates in two segments namely; fertilisers products; and AI health & elderly care products and services. The company generates a majority of its revenue from the Fertilisers products segment. The People's Republic of China is the primary geographical market for the company.
28GF Score
Get the complete analysis for FRA:TJJ
10-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:TJJ has been successfully added to your 
